Literature DB >> 2846896

Construction and application of plasmids containing bidirectional promoters of vaccinia virus.

H Tsao1, G Q Liu, L Ruan, C M Chu.   

Abstract

A bidirectional expression vector containing both the 11KD late promoter (p11) and the presumptive 25KD early promoter (p25) was constructed. These bidirectional vectors have been applied to the expression of hepatitis B surface antigen by using one of the promoters for beta-galactosidase as the marker gene and the other one for hepatitis B surface antigen as the target gene.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2846896      PMCID： PMC253610     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  6 in total

1.  Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.

Authors:  J L Rosel; P L Earl; J P Weir; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

2.  Gene coding for the late 11,000-dalton polypeptide of the Tian Tan strain of vaccinia virus and its 5'-flanking region: nucleotide sequence.

Authors:  H Tsao; G F Ren; C M Chu
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  In vitro gene fusions that join an enzymatically active beta-galactosidase segment to amino-terminal fragments of exogenous proteins: Escherichia coli plasmid vectors for the detection and cloning of translational initiation signals.

Authors:  M J Casadaban; J Chou; S N Cohen
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

4.  Transcriptional and translational analysis of a strongly expressed early region of the vaccinia virus genome.

Authors:  F Golini; J R Kates
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

5.  Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.

Authors:  J P Weir; G Bajszár; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Recovery of DNA fragments inserted by the "tailing" method: regeneration of PstI restriction sites.

Authors:  A Otsuka
Journal:  Gene       Date:  1981-05       Impact factor: 3.688
  6 in total
  7 in total

1.  Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene.

Authors:  J Vialard; M Lalumière; T Vernet; D Briedis; G Alkhatib; D Henning; D Levin; C Richardson
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 2.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques.

Authors:  Bo Wen; Yao Deng; Hong Chen; Jie Guan; Xia Chuai; Li Ruan; Wei Kong; Wenjie Tan
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

4.  Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.

Authors:  Hong Chen; Xia Chuai; Yao Deng; Bo Wen; Wen Wang; Shaoqing Xiong; Li Ruan; Wenjie Tan
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

5.  Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.

Authors:  Jie Guan; Bo Wen; Yao Deng; Ke Zhang; Hong Chen; Xiaobing Wu; Li Ruan; Wenjie Tan
Journal:  Virol J       Date:  2011-11-04       Impact factor: 4.099

6.  Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China.

Authors:  Weizheng Yan; Baoying Huang; Li Ruan; Wenjie Tan
Journal:  Protein Cell       Date:  2017-09       Impact factor: 14.870

7.  A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice.

Authors:  Yao Deng; Ke Zhang; Wenjie Tan; Yue Wang; Hong Chen; Xiaobing Wu; Li Ruan
Journal:  Vaccine       Date:  2009-02-12       Impact factor: 3.641
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.